Alameda, CA, United States of America

David Kiewlich

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovations of David Kiewlich

Introduction

David Kiewlich is an accomplished inventor based in Alameda, CA. He has made significant contributions to the field of biotechnology, particularly in the development of genetically modified stem cells. With a total of six patents to his name, Kiewlich's work has the potential to impact medical treatments and therapies.

Latest Patents

Kiewlich's latest patents include groundbreaking research on genetically modified stem cells. One of his notable patents describes human transgenic beta cells that express fugetactic levels of CXCL12, aimed at providing therapeutic benefits to subjects in need. Additionally, he has developed methods for reducing elevated glucose levels, further showcasing his expertise in the field of biotechnology.

Career Highlights

Throughout his career, Kiewlich has worked with various companies, including SDF Biopharma Inc. and Wallkill Biopharma, Inc. His experience in these organizations has allowed him to refine his skills and contribute to innovative projects that advance the field of biopharmaceuticals.

Collaborations

Kiewlich has collaborated with notable professionals in his field, including Gerald F Swiss. These partnerships have fostered an environment of innovation and have led to the development of impactful technologies.

Conclusion

David Kiewlich's contributions to biotechnology through his patents and collaborations highlight his role as a significant inventor in the industry. His work continues to pave the way for advancements in medical science and treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…